tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RAPT Stock Latest News

Rapt Therapeutics price target lowered to $17 from $24 at Wells Fargo
The FlyRapt Therapeutics price target lowered to $17 from $24 at Wells Fargo
12d ago
RAPT
Rapt Therapeutics says workforce reduction affected 47 people
PremiumThe Fly
Rapt Therapeutics says workforce reduction affected 47 people
15d ago
RAPT
Rapt Therapeutics reports Q2 EPS (71c), consensus (72c)
PremiumThe Fly
Rapt Therapeutics reports Q2 EPS (71c), consensus (72c)
15d ago
RAPT
RAPT Therapeutics Reports Second Quarter 2024 Financial Results
PremiumPress Releases
RAPT Therapeutics Reports Second Quarter 2024 Financial Results
15d ago
RAPT
Roblox downgraded, Western Digital initiated: Wall Street’s top analyst calls
PremiumThe Fly
Roblox downgraded, Western Digital initiated: Wall Street’s top analyst calls
3M ago
EW
GXO
Rapt Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
PremiumThe FlyRapt Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
3M ago
RAPT
Rapt Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
Premium
The Fly
Rapt Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
3M ago
RAPT
Guggenheim downgrades Rapt Therapeutics on lack of clarity
Premium
The Fly
Guggenheim downgrades Rapt Therapeutics on lack of clarity
4M ago
RAPT
Rapt Therapeutics downgraded to Equal Weight from Overweight at Barclays
PremiumThe Fly
Rapt Therapeutics downgraded to Equal Weight from Overweight at Barclays
4M ago
RAPT
Rapt Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Rapt Therapeutics downgraded to Neutral from Buy at Guggenheim
4M ago
RAPT
RAPT Therapeutics trading resumes
PremiumThe Fly
RAPT Therapeutics trading resumes
4M ago
RAPT
RAPT Therapeutics trading halted, volatility trading pause
PremiumThe Fly
RAPT Therapeutics trading halted, volatility trading pause
4M ago
RAPT
Rapt Therapeutics reports Q1 EPS (79c), consensus (81c)
PremiumThe FlyRapt Therapeutics reports Q1 EPS (79c), consensus (81c)
4M ago
RAPT
RAPT Therapeutics Reports First Quarter 2024 Financial Results
Premium
Press Releases
RAPT Therapeutics Reports First Quarter 2024 Financial Results
4M ago
RAPT
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
ADIL
ALPN
Rapt Therapeutics announces results from Phase 2 trial of tivumecirnon
PremiumThe Fly
Rapt Therapeutics announces results from Phase 2 trial of tivumecirnon
5M ago
RAPT
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
PremiumPress Releases
RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients
5M ago
RAPT
Rapt Therapeutics price target lowered to $13 from $15 at JPMorgan
PremiumThe Fly
Rapt Therapeutics price target lowered to $13 from $15 at JPMorgan
5M ago
RAPT
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
6M ago
RAPT
Rapt Therapeutics reports Q4 EPS (80c), consensus (86c)
PremiumThe FlyRapt Therapeutics reports Q4 EPS (80c), consensus (86c)
6M ago
RAPT
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
Premium
Press Releases
RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
6M ago
RAPT
Rapt Therapeutics Inc (RAPT) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Rapt Therapeutics Inc (RAPT) Q4 Earnings Cheat Sheet
6M ago
RAPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >